Hepatocellular carcinoma (HCC) is one of the commonest cancers worldwide, particularly in
parts of the developing world, and is increasing in incidence. This article reviews the current …

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. The
majority of HCCs develop in cirrhotic livers, and the early detection and characterization of …

Metabolic processes utilize a variety of differing and contrasting biochemical routes to
enable synthesis of degradation and activation or deactivation of substances; in addition …

Vascular endothelial growth factor (VEGF) is thought to take an important role in tumor
angiogenesis. The present study examined VEGF expression immunohistochemically in …

BACKGROUND Portal venous invasion (PVI) in patients with hepatocellular carcinoma
(HCC) is an important factor affecting prognosis. The objective of this study was to elucidate …

To clarify the course of adenomatous hyperplasia (AH) of the liver, 17 patients with 20
biopsy-proven AH nodules were followed clinically for 1-5 years. At the initial biopsy the …

Thirty-one patients with hepatocellular carcinoma (HCC) were given either an intraarterial
injection of iodized poppyseed oil (Lipiodol) alone (group A, n= 6), an emulsion of iodized oil …

PURPOSE: To evaluate the added value of hepatic arterial-dominant phase (HAP) imaging
to portal venous-dominant phase (PVP) imaging in patients with hepatocellular carcinoma …

Hepatocellular carcinoma (HCC) is a typical hypervascular tumor. However, the relationship
between the vascularity of HCC and the expression of angiogenic factors has not been …

BACKGROUND Hepatocellular carcinoma (HCC) with portal venous invasion (PVI) has a
very poor prognosis, with a median survival of 3 months and virtually no survival at 1 year …